Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FAM76A pseudogene 1 (FAM76AP1) is a non-protein coding segment of DNA classified as a pseudogene, originally derived from the FAM76A gene. Pseudogenes like FAM76AP1 typically do not produce functional proteins, though some may be transcribed and regulate gene expression via RNA mechanisms[3][4]. There is no known evidence of drugs interacting with FAM76AP1, nor does it serve as a validated biomarker or therapeutic target. If your research is concerned with receptor, enzyme, or transporter targets, FAM76AP1 may not be relevant, and it may be better to focus on the protein-coding gene FAM76A instead[1][2]. Key note: Most data sources (including Harmonizome and Wikipedia) do not list FAM76AP1 as a functional gene or therapeutic target but focus on FAM76A—the protein-coding gene. Pseudogenes like FAM76AP1 might influence biology at the RNA level but are not considered drug targets in standard pharmacopeia or target databases. Pseudogenes sometimes regulate gene expression and have been implicated in disease through indirect regulatory mechanisms, but detailed roles must be established for each pseudogene individually[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FAM76A pseudogene 1 (FAM76AP1).